Editorial · 31 Jan 2025
Mini reviewPublished 30 Dec 2023
Pharmacokinetics of Vacomycin
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vancomycin, a glycopeptide antibiotic renowned for its efficacy against gram-positive bacterial infections, has beena mainstay in the treatment of serious infections, particularly those caused by methicillin-resistant Staphylococcusaureus (MRSA). Vancomycin is primarily administered intravenously due to its negligible oral absorption. The drugexhibits a large volume of distribution, predominantly in the extracellular fluid, with limited penetration through theblood-brain barrier. Despite its significant role in combating infections, Vancomycin is not metabolized extensivelyin the body. Dosing adjustments are crucial, particularly in patients with impaired renal function, to prevent drug accumulation and associated toxicity. Extended interval dosing strategies may be employed to optimize efficacy while minimizing nephrotoxic and ototoxic risks. Special populations, including pediatric and elderly patients, as well as those with obesity, may require individualized dosing approaches.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacokinetics & Experimental Therapeutics.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacokinetics & Experimental Therapeutics
- SubjectPharmaceutical Sciences
